CHAMPIONS ONCOLOGY, INC. Retained Earnings
CHAMPIONS ONCOLOGY, INC. (CSBR) had Retained Earnings of -$81.49 million as of 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-09-11
- 2026-07-31: Retained Earnings (Accumulated Deficit) -$81.49M.
- 2026-04-30: Retained Earnings (Accumulated Deficit) -$81.07M.
- 2026-01-31: Retained Earnings (Accumulated Deficit) -$80.40M.
- 2025-10-31: Retained Earnings (Accumulated Deficit) -$80.12M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-07-31 | -$81.49M 10-Q · filed 2026-09-11 | |
| 2026-04-30 | -$81.07M 10-Q · filed 2026-09-11 | |
| 2026-01-31 | -$80.40M 10-Q · filed 2026-03-12 | |
| 2025-10-31 | -$80.12M 10-Q · filed 2025-12-15 | |
| 2025-07-31 | -$80.36M 10-Q · filed 2025-09-15 | |
| 2025-04-30 | -$79.89M 10-K · filed 2026-07-27 | |
| 2025-01-31 | -$78.06M 10-Q · filed 2025-03-17 | |
| 2024-10-31 | -$82.55M 10-Q · filed 2024-12-16 | |
| 2024-07-31 | -$83.28M 10-Q · filed 2024-09-13 | |
| 2024-04-30 | -$84.59M 10-K · filed 2025-07-23 | |
| 2024-01-31 | -$84.48M 10-Q · filed 2024-03-15 | |
| 2023-10-31 | -$81.95M 10-Q · filed 2023-12-13 | |
| 2023-07-31 | -$79.88M 10-Q · filed 2023-09-13 | |
| 2023-04-30 | -$77.32M 10-K · filed 2024-07-19 | |
| 2023-01-31 | -$74.76M 10-Q · filed 2023-03-16 | |
| 2022-10-31 | -$72.32M 10-Q · filed 2022-12-13 | |
| 2022-07-31 | -$72.30M 10-Q · filed 2022-09-12 | |
| 2022-04-30 | -$71.98M 10-K · filed 2023-07-24 | |
| 2022-01-31 | -$71.64M 10-Q · filed 2022-03-15 | |
| 2021-10-31 | -$72.42M 10-Q · filed 2021-12-13 | |
| 2021-07-31 | -$72.70M 10-Q · filed 2021-09-13 | |
| 2021-04-30 | -$72.53M 10-K · filed 2022-07-22 | |
| 2021-01-31 | -$71.64M 10-K · filed 2021-07-26 | -$71.86M 10-Q · filed 2021-03-15 |
| 2020-10-31 | -$72.60M 10-Q · filed 2020-12-14 | |
| 2020-07-31 | -$72.60M 10-Q · filed 2020-09-14 | |
| 2020-04-30 | -$72.89M 10-K · filed 2021-07-26 | -$72.67M 10-K · filed 2020-07-28 |
| 2020-01-31 | -$70.63M 10-Q · filed 2020-03-16 | |
| 2019-10-31 | -$71.03M 10-Q · filed 2019-12-16 | |
| 2019-07-31 | -$71.34M 10-Q · filed 2019-09-16 | |
| 2019-04-30 | -$70.70M 10-K · filed 2020-07-28 | |
| 2019-01-31 | -$70.44M 10-Q · filed 2019-03-18 | |
| 2018-10-31 | -$70.08M 10-Q · filed 2018-12-17 | |
| 2018-07-31 | -$70.34M 10-Q · filed 2018-09-14 | |
| 2018-04-30 | -$70.83M 10-K · filed 2019-07-29 | |
| 2018-01-31 | -$70.19M 10-Q · filed 2018-03-19 | |
| 2017-10-31 | -$70.12M 10-Q · filed 2017-12-15 | |
| 2017-07-31 | -$70.02M 10-Q · filed 2017-09-14 | |
| 2017-04-30 | -$69.35M 10-K · filed 2018-07-30 | |
| 2017-01-31 | -$66.92M 10-Q · filed 2017-03-17 | |
| 2016-10-31 | -$65.52M 10-Q · filed 2016-12-14 | |
| 2016-07-31 | -$65.01M 10-Q · filed 2016-09-14 | |
| 2016-04-30 | -$62.47M 10-K · filed 2017-07-28 | |
| 2016-01-31 | -$59.89M 10-Q · filed 2016-03-16 | |
| 2015-10-31 | -$57.48M 10-Q · filed 2015-12-15 | |
| 2015-07-31 | -$54.93M 10-Q · filed 2015-09-11 | |
| 2015-04-30 | -$52.02M 10-K · filed 2016-07-29 | |
| 2015-01-31 | -$48.35M 10-Q · filed 2015-03-17 | |
| 2014-10-31 | -$45.56M 10-Q · filed 2014-12-15 | |
| 2014-07-31 | -$42.45M 10-Q · filed 2014-09-12 | |
| 2014-04-30 | -$38.88M 10-K · filed 2015-07-29 | |
| 2014-01-31 | -$36.62M 10-Q · filed 2014-03-14 | |
| 2013-10-31 | -$36.02M 10-Q · filed 2013-12-13 | |
| 2013-07-31 | -$33.70M 10-Q · filed 2013-09-13 | |
| 2013-04-30 | -$31.47M 10-K · filed 2014-07-28 | |
| 2013-01-31 | -$29.43M 10-Q · filed 2013-03-13 | |
| 2012-10-31 | -$28.44M 10-Q · filed 2012-12-13 | |
| 2012-07-31 | -$26.47M 10-Q · filed 2012-09-12 | |
| 2012-04-30 | -$25.14M 10-K · filed 2013-07-26 | |
| 2012-01-31 | -$22.59M 10-Q · filed 2012-03-14 | |
| 2011-10-31 | -$20.87M 10-Q · filed 2011-12-14 | |
| 2011-07-31 | -$18.52M 10-Q · filed 2011-09-13 | |
| 2011-04-30 | -$16.48M 10-K · filed 2012-07-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |